Literature DB >> 11009446

Effect of hypercholesterolemia on Ca(2+)-dependent K(+) channel-mediated vasodilatation in vivo.

R W Jeremy1, H McCarron.   

Abstract

Nitric oxide (NO)-mediated and NO-independent mechanisms of endothelium-dependent vasodilatation involve Ca(2+)-dependent K(+) (K(Ca)) channels. We examined the role in vivo of K(Ca) channels in NO-independent vasodilatation in hypercholesterolemia. Hindlimb vascular conductance was measured at rest and after aortic injection of ACh, bradykinin (BK), and sodium nitroprusside in anesthetized control and cholesterol-fed rabbits. Conductances were measured before and after treatment with the NO synthase antagonist N(omega)-nitro-L-arginine methyl ester (L-NAME, 10 mg/kg) or K(Ca) blockers tetraethylammonium (30 mg/kg), charybdotoxin (10 microgram/kg), and apamin (50 microgram/kg). The contribution of NO to basal conductance was greater in control than in cholesterol-fed rabbits [2.2 +/- 0.4 vs. 1.1 +/- 0.3 (SE) ml. min(-1). kg(-1). 100 mmHg(-1), P < 0.05], but the NO-independent K(Ca) channel-mediated component was greater in the cholesterol-fed than in the control group (1.1 + 0.4 vs. 0.3 +/- 0.1 ml. min(-1). kg(-1). 100 mmHg(-1), P < 0.05). Maximum conductance response to ACh and BK was less in cholesterol-fed than in control rabbits, and the difference persisted after L-NAME (ACh: 7.7 +/- 0.7 vs. 10.1 +/- 0.5 ml. min(-1). kg(-1). 100 mmHg(-1), P < 0.005). Blockade of K(Ca) channels with tetraethylammonium or charybdotoxin + apamin almost completely abolished L-NAME-resistant vasodilatation after ACh or BK. The magnitude of K(Ca)-mediated vasodilatation after ACh or BK was impaired in hypercholesterolemic rabbits. Vasodilator responses to nitroprusside did not differ between groups. In vivo, hypercholesterolemia is associated with an altered balance between NO-mediated and NO-independent K(Ca) channel contributions to resting vasomotor tone and impairment of both mechanisms of endothelium-dependent vasodilatation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11009446     DOI: 10.1152/ajpheart.2000.279.4.H1600

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  7 in total

1.  Multiple cholesterol recognition/interaction amino acid consensus (CRAC) motifs in cytosolic C tail of Slo1 subunit determine cholesterol sensitivity of Ca2+- and voltage-gated K+ (BK) channels.

Authors:  Aditya K Singh; Jacob McMillan; Anna N Bukiya; Brittany Burton; Abby L Parrill; Alex M Dopico
Journal:  J Biol Chem       Date:  2012-04-03       Impact factor: 5.157

Review 2.  Cholesterol and ion channels.

Authors:  Irena Levitan; Yun Fang; Avia Rosenhouse-Dantsker; Victor Romanenko
Journal:  Subcell Biochem       Date:  2010

3.  Mediators of CD18/P-selectin-dependent constriction of venule-paired arterioles in hypercholesterolemia.

Authors:  Min-ho Kim; D Neil Granger; Norman R Harris
Journal:  Microvasc Res       Date:  2006-12-08       Impact factor: 3.514

4.  Targeting Lipid-Ion Channel Interactions in Cardiovascular Disease.

Authors:  Emma C Hudgins; Adam M Bonar; Thanh Nguyen; Ibra S Fancher
Journal:  Front Cardiovasc Med       Date:  2022-05-06

5.  Effects of exercise training and hypercholesterolemia on adenosine activation of voltage-dependent K+ channels in coronary arterioles.

Authors:  Cristine L Heaps; Elise C Jeffery; Glen A Laine; Elmer M Price; Douglas K Bowles
Journal:  J Appl Physiol (1985)       Date:  2008-10-02

Review 6.  Large conductance, calcium- and voltage-gated potassium (BK) channels: regulation by cholesterol.

Authors:  Alejandro M Dopico; Anna N Bukiya; Aditya K Singh
Journal:  Pharmacol Ther       Date:  2012-05-11       Impact factor: 12.310

Review 7.  Calcium signaling phenomena in heart diseases: a perspective.

Authors:  Sajal Chakraborti; Sudip Das; Pulak Kar; Biswarup Ghosh; Krishna Samanta; Saurav Kolley; Samarendranath Ghosh; Soumitra Roy; Tapati Chakraborti
Journal:  Mol Cell Biochem       Date:  2006-11-21       Impact factor: 3.842

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.